Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-22

Clinical Trial Update: Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects. [Phase 1]

View source ↗

Summary

This Phase 1 study investigates whether fostamatinib affects blood concentrations of rifampicin in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fostamatinib (fostamatinib)
  • Rifampicin

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis, Healthy Volunteers | Phase 1 | Status: COMPLETED